TY - T1的分享服务利用可穿戴脑电图对小儿癫痫患者在几内亚的资源匮乏环境:一个前瞻性研究。乔(N5.001) JF -首页神经-神经学六世- 92 - 15补充SP N5.001 AU -珍妮弗·威廉姆斯盟飘流打倒西塞AU -迈克Schaekermann盟Foksuna Sakadi盟——娜娜Rahamatou Tassiou AU - Aissatou建大BAH盟Abdoul Bachir Djibo Hamani盟Andrew Lim - AU -爱德华·c·w·梁盟Tadeu a Fantaneau AU -特蕾西Milligan盟Vidita Khatri AU -丹尼尔·霍克盟Manav Vyas以及非盟-爱丽丝Lam盟Gladia和田AU -约瑟夫·科恩AU -伊迪丝法盟法拉Mateen Y1 - 2019/04/09 UR - //www.ez-admanager.com/content/92/15_Supplement/N5.001.abstract N2 -目的:比较的能力分享服务应用,智能手机的大脑Scanner-2 (SBS2)和pre-placed脑电图帽(Easycap),成本~ 300美元,来检测与标准脑电图异常。背景:需要可靠的、可访问的和成本有效的脑电图技术在资源有限的环境中。SBS-2是一种便携式,可穿戴设备利用14频道EasyCap由人员轻松几小时后培训。数据传输通过无线远程安卓平板电脑和阅读专家神经。设计/方法:孩子们在迪恩医院,科纳克里,2017年11月。参与者会见了ILAE癫痫和顺序有一个标准的定义21领先Xltek脑电图和EasyCap脑电图利用SBS-2 14领先技术。脑电图所读远程专家临床神经生理学在美国和加拿大。完全无法解释的质量分数(清廉,0,10完美)也提供。结果:97例(49岁男性,平均年龄10年)登记。一个标准(1.0%),11(11.3%)的SBS-2脑电图由于人工制品是无法解释的。意味着质量分数为7.37和6.76标准和SBS-2脑电图。两个病人一个标准的脑电图但不是SBS-2脑电图,产生83对研究进行分析。 Mean recording time for standard and SBS-2 EEGs was 22.9 and 27.9 minutes respectively. Fifty-six(67.4%) standard EEGs and 31(37.3%) SBS-2 EEGs were abnormal. The sensitivity and specificity for any abnormality was 0.52 (CI 0.378,0.658) and 0.93 (CI 0.801,1.00). Epileptiform discharges were detected on 21 (25.3%) SBS-2 and 30 (36.1%) of standard EEGs. The SBS-2 had a sensitivity of 0.52 (CI 95% 0.324,0.708) and a specificity of 0.90(CI 95% 0.814,.944) for epileptiform discharges with positive and negative predictive values of 0.762 and 0.758.Conclusions: The SBS-2 application and EasyCap wearable device is easy to administer, moderately sensitive but highly specific for detection of EEG and epileptiform abnormalities in pediatric epilepsies.Disclosure: Dr. Williams has nothing to disclose. Dr. Cisse has nothing to disclose. Dr. Schaekermann has nothing to disclose. Dr. Sakadi has nothing to disclose. Dr. Tassiou has nothing to disclose. Dr. Bah has nothing to disclose. Dr. Djibo Hamani has nothing to disclose. Dr. Lim has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Phillips-Respironics. Dr. Leung has nothing to disclose. Dr. Fantaneau has nothing to disclose. Dr. Milligan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen. Dr. Khatri has nothing to disclose. Dr. Hoch has nothing to disclose. Dr. Vyas has nothing to disclose. Dr. Lam has nothing to disclose. Dr. Hotan has nothing to disclose. Dr. Cohen has nothing to disclose. Dr. Law has nothing to disclose. Dr. Mateen has nothing to disclose. ER -